Incremental cost-effectiveness of drug-eluting stents compared with a third-generation bare-metal stent in a real-world setting: randomised Basel Stent Kosten Effektivitäts Trial (BASKET)
- 1 September 2005
- journal article
- clinical trial
- Published by Elsevier BV in The Lancet
- Vol. 366 (9489), 921-929
- https://doi.org/10.1016/s0140-6736(05)67221-2
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- One year cost effectiveness of sirolimus eluting stents compared with bare metal stents in the treatment of single native de novo coronary lesions: an analysis from the RAVEL trialHeart, 2005
- Economic evaluation of sirolimus-eluting stentsCMAJ : Canadian Medical Association Journal, 2005
- The dollars and sense of drug-eluting stentsCMAJ : Canadian Medical Association Journal, 2005
- Unrestricted Utilization of Sirolimus-Eluting Stents Compared With Conventional Bare Stent Implantation in the “Real World”Circulation, 2004
- Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary ArteryNew England Journal of Medicine, 2003
- A single European currency for EQ-5D health statesThe European Journal of Health Economics, 2003
- Randomized Study to Assess the Effectiveness of Slow- and Moderate-Release Polymer-Based Paclitaxel-Eluting Stents for Coronary Artery LesionsCirculation, 2003
- Hippocrates RevisitedCirculation, 2003
- Drug-Eluting StentsCirculation, 2003
- Myocardial infarction redefined—A consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial InfarctionEuropean Heart Journal, 2000